Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00825799 · ClinicalTrials.gov registry record
Serum Markers as a Bioassay for Unipolar Depression
A clinical trial of Major Depression, sponsored by Steward St. Elizabeth's Medical Center of Boston.
- Completed
- Registry status
- 160
- Enrollment target
- 1
- Study location
NCT00825799: Completed study of Major Depression, sponsored by Steward St. Elizabeth's Medical Center of Boston.
NCT00825799 is a study of Major Depression that has completed, run by Steward St. Elizabeth's Medical Center of Boston. The registered enrollment target is 160 participants, below the 322-participant average among 28 other Major Depression trials with a reported enrollment target (50% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00825799, a study of Major Depression, has completed, sponsored by Steward St. Elizabeth's Medical Center of Boston.
- COMPLETED
- Registry status
- 160 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of the study is to validate a biomarker assay for unipolar depression based on serum proteins involved in inflammation, metabolism, and stress response. The study will compare patients with a current major depressive episode to individuals with no history of depression. The hypothesis is that the assay can serve as a diagnostic tool that would be more objective than standard diagnostic questionnaires.
Conditions Studied
Study Locations (1)
Massachusetts
- Steward St. Elizabeth's Medical Center - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 160 participants |
| Start Date | 2007-11 |
| Est. Completion | 2011-05 |
What the finished NCT00825799 record still lists
NCT00825799 is an observational study that tracks outcomes without assigning an intervention. The registered 160 participants enrollment target is mid-sized for trials with a published cap, below the 322-participant average among 28 other Major Depression trials with a reported enrollment target (50% lower).
The record links to 1 condition, with Major Depression appearing as the primary indexed condition, and to 0 interventions.
NCT00825799 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT00825799 about?
NCT00825799 is a clinical study titled "Serum Markers as a Bioassay for Unipolar Depression". The goal of the study is to validate a biomarker assay for unipolar depression based on serum proteins involved in inflammation, metabolism, and stress response. The study will compare patients with a current major depressive episode to individuals with no history of depression. The hypothesis is th...
What is the current status of trial NCT00825799?
This trial is currently completed. The enrollment target is 160 participants. The study started on 2007-11. Estimated completion is 2011-05.
What conditions does trial NCT00825799 study?
This clinical trial studies the following conditions: Major Depression.
Who is sponsoring clinical trial NCT00825799?
This trial is sponsored by Steward St. Elizabeth's Medical Center of Boston, which has 18 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00825799 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Major Depression
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00825799's enrollment target sits among peer trials
160 12th of 28 higher than 17 of 28 other Major Depression trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Major Depression trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Mechanism of Action Underlying Ketamine's Antidepressant Effects: The AMPA Throughput Theory in Patients With Treatment-Resistant Major Depression
RECRUITING · Phase 1
-
University of Iowa Interventional Psychiatry Service Patient Registry
RECRUITING
-
NIMH Rhythms and Blues Study: A Prospective Natural History Study of Motor Activity, Mood States, and Bipolar Disorder
RECRUITING
-
Leucine in Midlife Depression
RECRUITING · Phase 2
-
Ketamine Alcohol (in Treatment-Resistant Depression)
RECRUITING · Phase 2
-
Characterizing Cognitive Decline in Late Life Depression: The ADNI Depression Project
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00501826 · 160 participants · Phase 2
Combination Chemotherapy and Nelarabine in Treating Patients With T-cell Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma
- NCT00932139 · 160 participants · NA
Effect of Electro-Acupuncture on Blood Pressure
- NCT00992901 · 160 participants · Early Phase 1
Role of Neural and Hormonal Regulation Factors on Insulin Secretion After Gastric Bypass Surgery
- NCT01515527 · 160 participants · Phase 2
Cladribine Plus Low Dose Cytarabine (LDAC) Alternating With Decitabine in Patients With Acute Myeloid Leukemia (AML) or High-Risk Myelodysplastic Syndrome (MDS)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia